Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2000 | 06-2000 | 03-2000 | 12-1999 | 09-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,200 | -6,279 | -2,951 | -13,960 | -7,790 |
| Depreciation Amortization | 22 | 18 | 15 | 40 | 10 |
| Other Working Capital | 590 | 41 | 794 | 200 | 270 |
| Other Operating Activity | 654 | 593 | 333 | 5,700 | 2,060 |
| Operating Cash Flow | $-7,935 | $-5,627 | $-1,810 | $-8,020 | $-5,450 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -44 | -43 | -34 | -10 | -9 |
| Purchase Of Investment | -15,563 | -9,970 | -3,542 | -12,828 | N/A |
| Sale Of Investment | 10,414 | 7,019 | 3,228 | 5,347 | N/A |
| Other Investing Activity | -3 | 0 | -2 | -78 | -3,131 |
| Investing Cash Flow | $-5,196 | $-2,994 | $-351 | $-7,570 | $-3,140 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 8,000 | N/A |
| Common Stock Issued | 14,477 | 13,050 | 2,468 | 3,614 | N/A |
| Other Financing Activity | -79 | -61 | 0 | 4,176 | 16,540 |
| Financing Cash Flow | $14,398 | $12,989 | $2,468 | $15,790 | $16,540 |
| Beginning Cash Position | 260 | 260 | 260 | 70 | 70 |
| End Cash Position | 1,527 | 4,629 | 568 | 260 | 8,010 |
| Net Cash Flow | $1,267 | $4,368 | $308 | $180 | $7,940 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,935 | -5,627 | -1,810 | -8,020 | -5,450 |
| Capital Expenditure | -44 | -43 | -34 | -12 | N/A |
| Free Cash Flow | -7,978 | -5,670 | -1,843 | -8,032 | -5,450 |